793
Views
77
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea

, , , , &
Pages 275-280 | Received 10 Sep 2009, Accepted 16 Nov 2009, Published online: 03 Feb 2010

References

  • European Antimicrobial Resistance Surveillance System (EARSS). Available at: http://www.rivm.nl/earss/database/ (accessed 16 April 2008).
  • Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 2008;14(Suppl 1):33–41.
  • Molstad S, Cars O, Struwe J. Strama—a Swedish working model for containment of antibiotic resistance. Euro Surveill 2008;13: pii: 19041.
  • Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162–71.
  • Pena C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, . Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect 2006;12:279–84.
  • Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008;62:1142–9.
  • Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851–3.
  • Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, . Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000;30:473–8.
  • Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, . Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008;14(Suppl 1):144–53.
  • Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008;14(Suppl 1):159–65.
  • Villegas MV, Kattan JN, Quinteros MG, Casellas JM. Prevalence of extended-spectrum beta-lactamases in South America. Clin Microbiol Infect 2008;14(Suppl 1):154–8.
  • United Nations World Tourism Organization. World tourist arrivals: from 800 million to 900 million in two years. UNWTO World Tourism Barometer 2008;6:1–26.
  • Mesa RJ, Blanc V, Blanch AR, Cortes P, Gonzalez JJ, Lavilla S, . Extended-spectrum beta-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J Antimicrob Chemother 2006;58:211–5.
  • Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 2008;57:441–8.
  • Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Canton R, . High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 2008;46:2796–9.
  • Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 2007;55:254–9.
  • Wollin HH. Infektionsdiagnostik 1:2: Infektioner i mag- och tarmkanalen. 2nd. 2002, Smittskyddinstitutet, Sweden.
  • The Swedish Reference Group for Antibiotics (SRGA) and its subcommittee on methodology (SRGA-M). SRGA's methods Database on the Internet. Available at: http://www.srga.org/ (accessed 4 November 2008).
  • Birkett CI, Ludlam HA, Woodford N, Brown DF, Brown NM, Roberts MT, . Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases. J Med Microbiol 2007;56:52–5.
  • Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, . Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997;41:647–53.
  • Healy M, Huong J, Bittner T, Lising M, Frye S, Raza S, . Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol 2005;43:199–207.
  • Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Int J Infect Dis 2008;12:256–64.
  • Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:4.
  • Mohamed Al-Agamy MH, El-Din Ashour MS, Wiegand I. First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents 2006;27:545–8.
  • Tangden T, Melhus A, Cars O, Lowdin E. Foreign travel a risk factor for colonization with ESBL-producing Enterobacteriaceae: a prospective study on Swedish travellers. 48th ICAAC/46th IDSA Washington DC October 25-28, 2008; Washington, 2008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.